ITUS Corporation
(NASDAQ : ITUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Electronic Technology » Computer Peripherals
symbolcompany%chnglast%shortavg$volume
WDCWestern Digital Corporation
0.61%92.912.2%$320.09m
NTAPNetApp, Inc.
1.76%56.052.9%$181.13m
STXSeagate Technology PLC
0.47%40.339.0%$173.61m
SYNASynaptics Incorporated
-0.32%39.9718.8%$60.80m
ZBRAZebra Technologies Corporation Class A
-0.19%108.564.2%$41.14m
EFIIElectronics For Imaging, Inc.
0.55%29.0613.0%$39.71m
PSTGPure Storage, Inc. Class A
2.51%18.357.6%$27.03m
LOGILogitech International S.A.
-1.26%35.934.9%$19.54m
AVIDAvid Technology, Inc.
6.98%7.0512.0%$3.67m
ITUSITUS Corporation
-1.97%2.980.4%$3.05m
QTMQuantum Corporation
6.13%4.850.6%$2.99m
IMMRImmersion Corporation
0.17%6.075.4%$1.49m
QBAKQualstar Corporation
-0.13%7.680.8%$0.65m
BCLIBrainstorm Cell Therapeutics Inc.
-2.44%4.005.3%$0.21m
ICADiCAD, Inc.
3.23%3.840.5%$0.16m

Company Profile

ITUS Corp. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered in Los Angeles, CA.